Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

filter by theme
Women's health
Endocrinology
Academic support
Non clinical
 contact us

Publications

HRA Pharma has collaborated on a number of scientific publications in the areas of women’s health and endocrinology – whether through scientific cooperation or sponsorship.

Pharmacy access to emergency contraception in Europe.
Ulmann A, Gainer E.Perspect Sex Reprod Health. 2002 Sep-Oct;34(5):271;
Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis.
Carré A, Castanet M, Sura-Trueba S, Szinnai G, Van Vliet G, Trochet D, Amiel J, Léger J, Czernichow P, Scotet V, Polak M. Hum Genet. 2007 Dec;122(5):467-76.
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells.
Xu Q, Ohara N, Chen W, Liu J, Sasaki H, Morikawa A, Sitruk-Ware R, Johansson ED, Maruo T. Hum Reprod. 2006;21(9):2408-16.
Progesterone receptor modulator for emergency contraception: a randomized controlled trial.
Creinin MD, Schlaff W, Archer DF, et al. Obstet Gynecol 2006;108:1089-97.
Progestogen-only emergency contraception.
Gainer E, Méry C, Ulmann A.J Fam Plann Reprod Health Care. 2003 Apr;29(2):60.
Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus.
Szinnai G, Lacroix L, Carré A, Guimiot F, Talbot M, Martinovic J, Delezoide, AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M.J Clin Endocrinol Metab. 2007 Jan;92(1):70-6.
Surfing on the morning after: analysis of an emergency contraception website.
Gainer E, Sollet C, Ulmann M, Lévy D, Ulmann A.Contraception. 2003 Mar;67(3):195-9.
The pharmacokinetics of 750 microg levonorgestrel following administration of one single dose or two doses at 12- or 24-h interval.
Tremblay D, Gainer E, Ulmann A.Contraception. 2001 Dec;64(6):327-31.
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?